Avantax Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
|
|||||
|
2025
Q1 | $578K | Sell |
|
|||||
|
2024
Q4 | $644K | Buy |
|
|||||
|
2024
Q3 | $669K | Sell |
|
|||||
|
2024
Q2 | $654K | Sell |
|
|||||
|
2024
Q1 | $913K | Buy |
|
|||||
|
2023
Q4 | $733K | Sell |
|
|||||
|
2023
Q3 | $1.01M | Sell |
|
|||||
|
2023
Q2 | $1.56M | Sell |
|
|||||
|
2023
Q1 | $1.55M | Sell |
|
|||||
|
2022
Q4 | $2.65M | Sell |
|
|||||
|
2022
Q3 | $3M | Buy |
|
|||||
|
2022
Q2 | $2.18M | Buy |
|
|||||
|
2022
Q1 | $2.47M | Buy |
|
|||||
|
2021
Q4 | $1.68M | Buy |
|
|||||
|
2021
Q3 | $1.72M | Buy |
|
|||||
|
2021
Q2 | $1.82M | Buy |
|
|||||
|
2021
Q1 | $1.81M | Sell |
|
|||||
|
2020
Q4 | $5.04M | Sell |
|
|||||
|
2020
Q3 | $5.1M | Buy |
|
|||||
|
2020
Q2 | $4.18M | Buy |
|
|||||
|
2020
Q1 | $1.13M | Buy |
|